MaryDickinsonChamberlinMD

Clinical Trials

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15

  Active, not recruiting

  Phase 3

• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06

  Active, not recruiting

  Phase 3

• Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy Start of enrollment: 2011 Feb 01

  Unknown status

  Not Applicable

• Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway Start of enrollment: 2012 Dec 01

  Terminated

  Not Applicable

• BKM120 for Patients With PI3K-activated Tumors Start of enrollment: 2013 Mar 29

  Completed

  Phase 2

• Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer Start of enrollment: 2013 Dec 01

  Terminated

• Genetically-informed Therapies for Patients With Metastatic Cancer Start of enrollment: 2014 Jan 01

  Withdrawn

  Phase 4

• A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer Start of enrollment: 2014 Jun 01

  Completed

  Not Applicable

• Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X) Start of enrollment: 2016 Feb 25

  Withdrawn

  Phase 2

• Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) Start of enrollment: 2021 Aug 13

  Recruiting

  Phase 2

• Join now to see all